Latest Publications

Share:

How to leverage Advanced Purchase Agreements for military supply

The EU is introducing new regulations (EDIRPA and EDIP) to structure military procurement through pooled orders coordinated by the European Commission. Advanced Purchase Agreements (APAs), inspired by COVID-19 contracts,...more

Evaluation of the French Egalim 2 law: a mixed review and prospects for evolution

A report issued on 11 February 2025 by the evaluation mission of the Egalim 2 law has evidenced that it is not possible at this stage to conclude on the economic effectiveness of the measures introduced by the law to protect...more

French simplifies regulations applicable to health care activity authorizations; health cooperation groups now entitled to hold...

The long-awaited Valletoux decree regularizes the exclusion of health cooperation groups for the ownership of certain health care activities’ authorizations in France, resulting from the 2022 reform of health care activities....more

Nouveaux modèles de convention unique pour la recherche clinique: plus de standardisation, moins de simplification

De nouveaux modèles de convention unique pour la recherche clinique ont été publiés le 5 aout 2024. Ceux-ci mettent à jour les précédents modèles en prenant en compte les nouvelles tendances de la pratique en matière de...more

New French template agreement for clinical trials: more standardization, less simplification

Two updates to the French national clinical trial template agreements (Convention Unique) were published on August 5, 2024. They update the previous templates to take into account evolving practices in clinical trials. In...more

Q2/2024 Life Science Law Update – Key developments for pharma & device companies in EU

The Q2/24 Life Science and Health Care Law Update covers key trends in the EU and Big Five (France, Germany, Italy, Spain, UK) in life sciences regulatory, corporate, compliance, competition, and privacy....more

Panelists discuss European pharmaceutical trends and how to stay ahead of the game - Life Sciences and Health Care Horizons event...

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Zurich, where co-head of Hogan Lovells Life Sciences and Health Care sector Jane Summerfield, and partners Melissa K. Bianchi,...more

The use of IVDs as CDx in pharmaceutical clinical trials - Pathways for legacy companion diagnostic IVDs, IVD performance studies,...

The current European legislation for in vitro diagnostic medical devices (IVD) (Regulation 2017/746 or the IVDR) has created challenges not only for IVD manufacturers but also for pharmaceutical companies....more

Nouvelle contrainte à la charge de l’industrie pharmaceutique dans la lutte contre les pénuries de médicaments

Un nouveau dispositif, porté par le projet de loi de financement de la sécurité sociale pour 2024, pourrait aboutir à imposer aux entreprises exploitant un médicament mature d’intérêt thérapeutique majeur qui souhaiterait en...more

New offensive against the pharmaceutical industry in the fight against medicinal product shortages

A new draft measure, included in the Social Security Financing Bill for 2024, aims to require companies operating a mature medicinal product of major therapeutic interest (MITM) that wishes to suspend or cease marketing it,...more

Collaborative research is blurring boundaries between sponsored studies and IIS

Industry is revising its models in clinical development: new collaborative research between the industry and investigators is becoming more important, resulting in an in-between approach between industry sponsored studies and...more

Panelists discuss how European pharmaceutical companies can stay ahead of the game

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Zurich, where co-head of Hogan Lovells Life Sciences and Health Care sector Jane Summerfield, and partners Melissa K. Bianchi,...more

The law aimed at improving the framework for French health care centers has finally been published!

The French law n° 2023-378 of 19 May 2023 on the supervision of health care centers has finally been published in the Journal Officiel. The text, which has reached a consensus, was adopted without major changes. This text is...more

6/2/2023  /  France , Healthcare

La loi visant à améliorer l’encadrement des centres de santé enfin publiée !

La loi n° 2023-378 du 19 mai 2023 relative à l’encadrement des centres de santé a enfin été publiée au Journal Officiel. Ce texte qui a fait consensus, a été adopté sans modification majeure par rapport au projet initialement...more

Successful product launches across the EU, UK, and U.S.

We were pleased to welcome industry leaders to our Life Sciences and Health Care Horizons event in Boston for the first time since the pandemic. At the event, Hogan Lovells attorneys Eliza Andonova, Ina Brock, Kristin...more

Regulation of health care centers: a limited reform on the way

A new bill of law has been proposed to improve the regulation of health care centers in France. While limited in scope as currently drafted, the bill contributes to the establishment of a regulatory framework applicable to...more

La réforme de l’encadrement des centres de santé, une réglementation attendue mais dont les contours restent encore limités

Une nouvelle proposition de loi est en cours d’adoption, visant à améliorer l’encadrement des centres de santé en France. Ce texte participe à la construction du cadre réglementaire applicable à la mise en place de ces...more

Dispositif Encadrement des avantages : actualisation de la liste des typologies thématiques des avantages et des conventions

Répondant aux critiques émanant de la pratique, un arrêté en date du 20 janvier 2023 a modifié l'arrêté du 24 septembre 2020 portant sur la typologie thématique des avantages et des conventions en application de l'article...more

French anti-benefits regulation: update of the list of thematic typologies of benefits and agreements

More than two years after the publication of the ministerial order of 24 September 2020 establishing a “thematic typology” of benefits and agreements provided for in Article R1453-14 of the French Public Health Code, a...more

Can sterile drug manufacturers implement EU GMP Annex 1 requirements before August?

In August 2022, the European Commission published a revision to Annex 1 “Manufacture of Sterile Medicinal Products” in EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines that will significantly impact...more

Loi de financement de la sécurité sociale pour 2023 : cadeau de fin d’année pour les sociétés de téléconsultation

La loi du 23 décembre 2022 de financement de la sécurité sociale pour 2023 a entériné l’adoption d’un nouveau régime d’agrément applicable aux sociétés de téléconsultation afin de favoriser la prise en charge des services de...more

Social Security Financing Law for 2023: a year-end gift for teleconsultation companies

The social security financing act for 2023, dated 23 December 2022, has endorsed the adoption of a new accreditation regime applicable to teleconsultation companies to facilitate the reimbursement of the teleconsultation...more

Online gaming regulatory practice in France - Part 1: T&C of video game digital distribution stores

The online gaming sector is characterized by various regulatory frameworks, that may or may not overlap depending on the type of games and means of distribution. There are a number of stakeholders on the value chain...more

Teleconsultations in France: a (r)evolution coming for commercial companies?

Analysis and update on a possible major evolution of the regulation applicable to telemedicine, currently borne by the Social Security Financing Bill for 2023 and being discussed by the French Parliament. The Social Security...more

Téléconsultations : (r)évolution à venir pour les sociétés commerciales ?

Analyse et point d’étape concernant une possible évolution majeure de la règlementation applicable aux actes de télémédecine qui est actuellement portée par le PLFSS 2023 et en cours de discussion devant le Parlement - Le...more

46 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide